News Search Results
Feb 26, 2025, 08:30 ET Halozyme to Participate in the TD Cowen 45th Annual Healthcare Conference
commercialized products across more than 100 global markets, Halozyme has licensed its ENHANZE® technology to leading pharmaceutical and biotechnology companies including Roche, Takeda, Pfizer, Janssen, AbbVie, Eli Lilly, Bristol-Myers Squibb, argenx, ViiV Healthcare, Chugai Pharmaceutical and
More news about: Halozyme Therapeutics, Inc.
Feb 26, 2025, 08:00 ET Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced has it has dosed its final patient in the third cohort of its ongoing
More news about: Anixa Biosciences, Inc.
Feb 26, 2025, 08:00 ET Kyowa Kirin Announces Late-Breaking Abstract Presentation at the American Academy of Dermatology Annual Meeting 2025
value. As a Japan-based Global Specialty Pharmaceutical Company, Kyowa Kirin has invested in drug discovery and biotechnology innovation for more than 70 years and is currently working to engineer the next generation of antibodies and cell and gene therapies with the potential
More news about: Kyowa Kirin
Feb 26, 2025, 07:00 ET Syantra and Mays Cancer Center at UT Health San Antonio collaborate on clinical studies with new funding award
CALGARY, AB, Feb. 26, 2025 /PRNewswire/ - Syantra, Inc., a precision biotechnology company revolutionizing cancer detection, today announced that it has received funding from Alberta Innovates to support expanded clinical studies
More news about: Syantra Inc.
Feb 26, 2025, 07:00 ET Adcendo ApS Announces U.S. FDA Clearance of IND Application for Phase I Tiffany-01 Trial of ADCE-T02
better safety profile, enhanced response rates and longer duration of About Adcendo ApS Adcendo ApS is a clinical-stage biotechnology company headquartered in Copenhagen, Denmark, with operations in Boston, Massachusetts.
More news about: Adcendo
Feb 26, 2025, 07:00 ET Adcendo ApS Announces U.S. FDA Clearance of IND Application for Phase I Tiffany-01 Trial of ADCE-T02
better safety profile, enhanced response rates and longer duration of About Adcendo ApS Adcendo ApS is a clinical-stage biotechnology company headquartered in Copenhagen, Denmark, with operations in Boston, Massachusetts.
More news about: Adcendo
Feb 26, 2025, 07:00 ET Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AA Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Severe-to-Very Severe Alopecia Areata
medical need for novel, more effective therapies for patients. About Nektar Therapeutics Nektar Therapeutics is a clinical-stage biotechnology company focused on developing treatments that address the underlying immunological dysfunction in autoimmune and chronic inflammatory diseases.
More news about: Nektar Therapeutics
Feb 26, 2025, 06:59 ET Q32 Bio to Participate in Upcoming March Investor Conferences
Feb. 26, 2025 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today announced that management will participate in two upcoming
More news about: Q32 Bio
Feb 26, 2025, 06:30 ET Immunic Presents Key Vidofludimus Calcium Data at the ACTRIMS Forum 2025, Highlighting Its Potential in Multiple Sclerosis
Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today
More news about: Immunic, Inc.
Feb 26, 2025, 02:51 ET BPC Instruments reports result for year 2024
instruments enabling more efficient, reliable, and higher quality research and analysis for industries in renewable bioenergy and environmental biotechnology. The result is not only higher accuracy and precision, but also a significant reduction in time consumption and labor requirement for performing
More news about: BPC Instruments AB
Feb 25, 2025, 21:45 ET ICLR Purchasers Have Opportunity to Lead ICON plc Securities Fraud Lawsuit
were insufficient to shield ICON from the adverse effects of a significant market downturn; (3) the requests for proposals ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: THE ROSEN LAW FIRM, P. A.
Feb 25, 2025, 19:03 ET HBM Alpha Therapeutics Enters Strategic Collaboration and License Agreement to Advance Novel Endocrine Therapies
Feb. 25, 2025 /PRNewswire/ -- HBM Alpha Therapeutics (HBMAT), Inc., an innovative biotechnology company incubated by Harbour BioMed (HKEX: 02142), announced a strategic collaboration and license agreement with a business partner to advance
More news about: Harbour BioMed
Feb 25, 2025, 18:30 ET REGN INVESTOR NOTICE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
e-mail at [email protected]. CASE ALLEGATIONS: Regeneron is a biotechnology company that designs products for eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, among others.
More news about: Robbins Geller Rudman & Dowd LLP
Feb 25, 2025, 17:31 ET Global Advanced Therapy Medicinal Products Market to Grow Immensely at a CAGR of ~14% by 2032 | DelveInsight
Therapeutics, Vivet Therapeutics, HELIXMITH Co, Rocket Pharmaceuticals, Bristol-Myers Squibb, Wellington Zhaotai Therapies, Reyon Pharmaceutical, Neowise Biotechnology, Orna Therapeutics, Genflow Biosciences, Xylocor Therapeutics, Kolon TissueGene, Allogene Therapeutics, Nanjing IASO Biotherapeutics, Shanghai Vitalgen
More news about: DelveInsight Business Research, LLP
Feb 25, 2025, 17:00 ET Einen neuen Standard für intelligente Fabriken setzen: Angel Yeast fördert die Zusammenarbeit von Mensch und Maschine in der intelligenten Produktion
Technology positioniert sich in den Bereichen nutrazeutische Inhaltsstoffe und funktionelle Materialien für die Körperpflege, während sich Hubei PHAngel Biotechnology der Entwicklung biologisch abbaubarer Materialien auf PHA-Biobasis widmet. Die symbiotische Wirkung der industriellen Kette ist besonders
More news about: Angel Yeast
Feb 25, 2025, 16:56 ET Établir une nouvelle norme pour les usines intelligentes : Angel Yeast favorise l'éco-collaboration et la coexistence homme-machine dans la production intelligente
Maiggic Technology se positionne sur les ingrédients nutraceutiques et les matériaux fonctionnels pour les soins personnels, tandis que Hubei PHAngel Biotechnology se consacre au développement de matériaux biodégradables d'origine biologique, les PHA L'effet symbiotique de la chaîne industrielle est
More news about: Angel Yeast
Feb 25, 2025, 16:38 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Revance Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - RVNC
[Click here for information about joining the class action] Revance is a biotechnology company that develops, manufactures, and commercializes neuromodulators for various aesthetic and therapeutic indications in the
More news about: Pomerantz LLP
Feb 25, 2025, 16:05 ET REGENXBIO to Participate in Upcoming Investor Conferences
available for approximately 30 days following the presentation. ABOUT REGENXBIO Inc.REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the development
More news about: REGENXBIO Inc.
Feb 25, 2025, 13:17 ET Estableciendo un nuevo estándar para las fábricas inteligentes por parte de Angel Yeast
Hubei Maiggic Technology se posiciona en ingredientes nutracéuticos y materiales funcionales para el cuidado personal, mientras que Hubei PHAngel Biotechnology se dedica al desarrollo de materiales biodegradables de base biológica PHA. El efecto simbiótico de la cadena industrial es particularmente
More news about: Angel Yeast
Feb 25, 2025, 12:00 ET K18 UNVEILS AstroLift™: A Game-Changing Reparative Volumizing Spray for Stylists and Consumers Alike
K18K18 is a next generation, biology-first haircare brand co-founded by Suveen Sahib that is transforming the haircare industry with advanced biotechnology. At the heart of K18's innovation is the patented K18PEPTIDE™, a high-performance ingredient that reverses hair damage in just four minutes. This
More news about: K18 Biomimetic Hairscience
Feb 25, 2025, 11:40 ET Mobile Cleanroom Market Set to Reach US$ 8.36 Billion by 2031, Driven by Growing Demand in Pharmaceuticals and Biotechnology
(Microelectronics Industry, Pharmaceuticals and Biotechnology Industry, Medical Device Manufacturers, and Others), and Geography" The global mobile cleanroom market is growing significantly with the increasing adoption of the technology in the pharmaceuticals and biotechnology industries. The mobile cleanroom market
More news about: The Insight Partners
Feb 25, 2025, 11:25 ET Organoid Services Market Size Projected to Reach US$15.01 Billion by 2031, Driven by Personalized Medicine and Innovative Drug Screening
studies. Such that, organoid services market is bound to surge forward with continuous innovation from drug-testing and drug studies by pharma and biotechnology companies besides research institutions around the globe.Increasing Demand for Innovative Drug Screening Services: Organoids
More news about: The Insight Partners
Feb 25, 2025, 11:10 ET Aquatic Veterinary Market Size Worth $1.93 billion Globally, by 2031 Growing at 3.7% CAGR | Exclusive Report by The Insight Partners
Thermo Fisher Scientific Inc.Trending Topics: Integrated pest management, telemedicine and remote diagnostics, personalized medicine, and biotechnology and genomics in veterinary diagnostics, among others.Global Headlines on Aquatic Veterinary Elanco
More news about: The Insight Partners
Feb 25, 2025, 10:45 ET Brain Health Supplements Market Size to Reach a Valuation of US$ 20.01 Billion by 2031, Driven by Increasing Mental Health Awareness | The Insight Partners
of depression is higher in Asia Pacific compared to the rest of the world. According to the National Centre for Biotechnology Information (NCBI), there is growing evidence about the role of nutrients in mental health. The adequate consumption of nutrients contributes to
More news about: The Insight Partners
Feb 25, 2025, 10:30 ET Marzipan Market Size to Reach a Worth US$ 1.51 Billion by 2031, Growing at 4.1% CAGR | Exclusive Report by The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners